Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001415889-15-000758

Director acquired 269,114,822 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schinazi Raymond F Director 2015-03-03 Option exercise +269,114,822 269,114,822 D
Derivatives
Schinazi Raymond F Director 2015-03-03 Option exercise · Series A Convertible Preferred Stock −789,747 0 D
Loading xslF345X03/form4-03052015_010346.xml…